Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

Presentation TCT 2018

Case Presentation: Deterioration of LV Systolic Function/Worsened Heart Failure Despite Successful TMVR

Presenter: James B. Hermiller Jr, Wilson Y. Szeto, Khalil Fattouch, Sameer Gafoor, Adam B. Greenbaum, Roger J. Laham, Ruediger S. Lange, Rashmi Yadav

September 24, 2018

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

Presentation

Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves

July 11, 2018

News Daily News

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Caitlin E. Cox

July 10, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

News Daily News

New Surgical Valve Durability Data Set ‘Critical Benchmark’ for TAVR Devices

Yael L. Maxwell

March 26, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

Advertisement

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Case Presentation: Deterioration of LV Systolic Function/Worsened Heart Failure Despite Successful TMVR

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

New Surgical Valve Durability Data Set ‘Critical Benchmark’ for TAVR Devices

Ticagrelor: Better Platelet Blockade Post-TAVR?

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content